North America Sterility Testing Market Size, Share & Industry Trends Analysis Report By Product, By Test Type (Membrane Filtration, Direct Inoculation and Others), By Application, By End User, By Country and Growth Forecast, 2023 - 2029

North America Sterility Testing Market Size, Share & Industry Trends Analysis Report By Product, By Test Type (Membrane Filtration, Direct Inoculation and Others), By Application, By End User, By Country and Growth Forecast, 2023 - 2029


The North America Sterility Testing Market would witness market growth of 9.7% CAGR during the forecast period (2023-2029).

Sterility testing is performed at all stages of producing pharmaceutical and biological goods to reduce the possibility of product contamination. The frequency of sterility testing in the industries is rising along with the demand for medical devices and pharmaceuticals for various health issues, which is anticipated to drive the market. Large investments in the market are thought to be a result of sterility testing & its related services gaining popularity over time.

In addition, the strict regulations defined by regulatory bodies such as FDA, have led to expansion of sterility testing market. Significant factors driving the growth of the sterility testing market include the expansion of the biotechnology & pharmaceutical sector and the rise in research & development initiatives in the life sciences industry.

Increased government initiatives in the biotechnology field and rising sterilized product demand, particularly in the healthcare industry, contribute to the market's overall expansion. Additional factors that speed up the market's overall expansion and contribute to its success over the projected period include government funding, rising healthcare expenditures, and the increasing usage of technologically advanced equipment in healthcare organizations.

The presence of numerous international pharmaceutical & biopharmaceutical businesses as well as significant financing for research & development by the government as well as private organizations in the United States are credited with the country's substantial market share in the sterility testing market. Furthermore, the market is expanding because of the increased incidence of diabetes and the Canadian government's increasing funding of research & development related to the disease.

The US market dominated the North America Sterility Testing Market by Country in 2022; thereby, achieving a market value of $598.8 million by 2029. The Canada market is experiencing a CAGR of 12.2% during (2023 - 2029). Additionally, The Mexico market would exhibit a CAGR of 11.3% during (2023 - 2029).

Based on Product, the market is segmented into Kits & Reagents, Instruments and Services. Based on Test Type, the market is segmented into Membrane Filtration, Direct Inoculation and Others. Based on Application, the market is segmented into Pharmaceuticals & Biologicals, Medical Devices and Others. Based on End User, the market is segmented into Pharmaceutical Companies, Biotechnology Companies and Others. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.

The market research report covers the analysis of key stakeholders of the market. Key companies profiled in the report include Thermo Fisher Scientific, Inc., Charles River Laboratories International, Inc., SGS S.A., Merck KGaA, BioMérieux S.A., WuXi AppTec Co., Ltd., Sartorius AG, Samsung Biologics Co., Ltd. (Samsung Group), Nelson Laboratories, LLC (Sotera Health Company) and Pacific Biolabs, Inc.

Scope of the Study

Market Segments covered in the Report:

By Product

Kits & Reagents
Instruments
Services
By Test Type

Membrane Filtration
Direct Inoculation
Others
By Application

Pharmaceuticals & Biologicals
Medical Devices
Others
By End User

Pharmaceutical Companies
Biotechnology Companies
Others
By Country

US
Canada
Mexico
Rest of North America
Companies Profiled

Thermo Fisher Scientific, Inc.
Charles River Laboratories International, Inc.
SGS S.A.
Merck KGaA
BioMérieux S.A.
WuXi AppTec Co., Ltd.
Sartorius AG
Samsung Biologics Co., Ltd. (Samsung Group)
Nelson Laboratories, LLC (Sotera Health Company)
Pacific Biolabs, Inc.
Unique Offerings from KBV Research

Exhaustive coverage
Highest number of market tables and figures
Subscription based model available
Guaranteed best price
Assured post sales research support with 10% customization free


Chapter
1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 North America Sterility Testing Market, by Product
1.4.2 North America Sterility Testing Market, by Test Type
1.4.3 North America Sterility Testing Market, by Application
1.4.4 North America Sterility Testing Market, by End User
1.4.5 North America Sterility Testing Market, by Country
1.5 Methodology for the research
Chapter
2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition & Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter
3. North America Sterility Testing Market by Product
3.1 North America Kits & Reagents Market by Country
3.2 North America Instruments Market by Country
3.3 North America Services Market by Country
Chapter
4. North America Sterility Testing Market by Test Type
4.1 North America Membrane Filtration Market by Country
4.2 North America Direct Inoculation Market by Country
4.3 North America Others Market by Country
Chapter
5. North America Sterility Testing Market by Application
5.1 North America Pharmaceuticals & Biologicals Market by Country
5.2 North America Medical Devices Market by Country
5.3 North America Others Market by Country
Chapter
6. North America Sterility Testing Market by End User
6.1 North America Pharmaceutical Companies Market by Country
6.2 North America Biotechnology Companies Market by Country
6.3 North America Others Market by Country
Chapter
7. North America Sterility Testing Market by Country
7.1 US Sterility Testing Market
7.1.1 US Sterility Testing Market by Product
7.1.2 US Sterility Testing Market by Test Type
7.1.3 US Sterility Testing Market by Application
7.1.4 US Sterility Testing Market by End User
7.2 Canada Sterility Testing Market
7.2.1 Canada Sterility Testing Market by Product
7.2.2 Canada Sterility Testing Market by Test Type
7.2.3 Canada Sterility Testing Market by Application
7.2.4 Canada Sterility Testing Market by End User
7.3 Mexico Sterility Testing Market
7.3.1 Mexico Sterility Testing Market by Product
7.3.2 Mexico Sterility Testing Market by Test Type
7.3.3 Mexico Sterility Testing Market by Application
7.3.4 Mexico Sterility Testing Market by End User
7.4 Rest of North America Sterility Testing Market
7.4.1 Rest of North America Sterility Testing Market by Product
7.4.2 Rest of North America Sterility Testing Market by Test Type
7.4.3 Rest of North America Sterility Testing Market by Application
7.4.4 Rest of North America Sterility Testing Market by End User
Chapter
8. Company Profiles
8.1 Thermo Fisher Scientific, Inc.
8.1.1 Company Overview
8.1.2 Financial Analysis
8.1.3 Segmental and Regional Analysis
8.1.4 Research & Development Expenses
8.1.5 Recent strategies and developments:
8.1.5.1 Product Launches and Product Expansions:
8.1.5.2 Geographical Expansions:
8.2 Charles River Laboratories International, Inc.
8.2.1 Company Overview
8.2.2 Financial Analysis
8.2.3 Segmental and Regional Analysis
8.2.4 Recent strategies and developments:
8.2.4.1 Product Launches and Product Expansions:
8.3 SGS S.A.
8.3.1 Company Overview
8.3.2 Financial Analysis
8.3.3 Segmental and Regional Analysis
8.3.4 Research & Development Expenses
8.4 Merck KGaA
8.4.1 Company Overview
8.4.2 Financial Analysis
8.4.3 Segmental and Regional Analysis
8.4.4 Research & Development Expense
8.5 BioMérieux S.A.
8.5.1 Company Overview
8.5.2 Financial Analysis
8.5.3 Segmental and Regional Analysis
8.5.4 Research & Development Expenses
8.5.5 Recent strategies and developments:
8.5.5.1 Partnerships, Collaborations, and Agreements:
8.5.5.2 Acquisition and Mergers:
8.6 WuXi AppTec Co., Ltd.
8.6.1 Company Overview
8.6.2 Financial Analysis
8.6.3 Segmental Analysis
8.6.4 Research & Development Expenses
8.6.5 Recent strategies and developments:
8.6.5.1 Geographical Expansions:
8.7 Sartorius AG
8.7.1 Company Overview
8.7.2 Financial Analysis
8.7.3 Segmental and Regional Analysis
8.7.4 Research & Development Expenses
8.8 Samsung Biologics Co., Ltd. (Samsung Group)
8.8.1 Company Overview
8.8.2 Financial Analysis
8.8.3 Regional Analysis
8.8.4 Research & Development Expenses
8.9 Nelson Laboratories, LLC (Sotera Health Company)
8.9.1 Company Overview
8.9.2 Financial Analysis
8.9.3 Segmental and Regional Analysis
8.10. Pacific Biolabs, Inc.
8.10.1 Company Overview

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings